CVS Health Corporation
Every calculator, already run for CVS
Open the full toolkit →You have the numbers on CVS. Get the argument.
A written report on which of these readings actually decide the outcome for CVS Health Corporation, what has to stay true for the price to work, and the specific thing that would break it. The first one is free.
Key market data
Analyst consensus
27 analysts covering CVSAnalyst Price Target Disagreement for CVS Health Corporation
Wall Street's bull case implies +71% from the current price; the bear case implies +19%. A 52% spread signals high analyst disagreement — run your own DCF to anchor on fundamentals rather than street consensus.
Ownership & short interest
Insider Trading Activity for CVS
| Insider | Role | Type | Shares | Price | Value | Date | Filing |
|---|---|---|---|---|---|---|---|
About CVS Health Corporation
CVS Health Corporation provides health solutions in the United States. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services, including medical, pharmacy, dental, and behavioral health plans; medical management capabilities; Medicare Advantage and Medicare Supplement plans; prescription drug plans (PDPs); and Medicaid health care management services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Health Services segment offers pharmacy benefit management s…
CVS — frequently asked
Is CVS a buy right now?
Wall Street's consensus rating on CVS Health Corporation is Strong Buy across 27 analysts, with a mean price target of $116.28 (+34% vs. the current $86.46). Ratings are a starting point — run the DCF and check the financial-health readings above before deciding.
Is CVS overvalued?
CVS trades at 22.8x trailing earnings, against a DCF fair value of $245 per share. The current price implies -7% annual free-cash-flow growth for a decade. Open the DCF or reverse-DCF tool to change the assumptions and see the range.
When is CVS's next earnings date?
CVS Health Corporation is next scheduled to report earnings around Oct 28, 2026. A full CVS research report from Basis Report covers the setup into that print — estimates, the beat/miss record, and what would move the thesis.
What is the analyst price target disagreement for CVS Health Corporation?
Analysts covering CVS Health Corporation (CVS) range from a bear-case target of $103.00 to a bull-case high of $148.00, with a mean consensus target of $116.28 across 25 analysts. The spread of $45.00 (52% of the current price) indicates high disagreement on the outlook. Run the DCF calculator to build your own estimate independent of street consensus.
Compare CVS Health Corporation against related stocks
Explore additional stock overview pages and jump directly into full report generation for each symbol.
Sector peers
Most-followed names in the same sector.
Nearby tickers
Additional public equities from our tracked universe.
Market leaders
Large-cap symbols investors frequently compare.
Investor Guides For CVS Health Corporation
Start with the evergreen guides that matter most for Healthcare, then move back into the ticker page when you want to pressure-test the framework on a live name.
Generate your full CVS research report
DCF model, five-year financials, moat assessment, a BUY/HOLD/SELL rating, and the risks that matter — on CVS Health Corporation, in minutes. 3 free reports included with every account — no credit card required.